Diabetes with ASCVD — ABFM Board MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Add a GLP-1 receptor agonist or SGLT2 inhibitor with cardiovascular benefit
In type 2 diabetes with established cardiovascular disease, agents with proven cardiovascular benefit should be considered independent of glucose lowering needs.
Reference: ADA Standards of Care in Diabetes 2026: https://professional.diabetes.org/standards-of-care